Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs.
about
Baseline HCV Antibody Prevalence and Risk Factors among Drug Users in China's National Methadone Maintenance Treatment ProgramUse of multiple data sources to estimate hepatitis C seroprevalence among prisoners: A retrospective cohort studyPortraying persons who inject drugs recently infected with hepatitis C accessing antiviral treatment: a cluster analysis.Community-based HCV screening: knowledge and attitudes in a high risk urban populationThe Cascade of Care for an Australian Community-Based Hepatitis C Treatment ServiceEpidemiology of hepatitis C virus infection among people receiving opioid substitution therapy (ECHO): study protocol.Self-Reported HIV and HCV Screening Rates and Serostatus Among Substance Abuse Treatment Patients.Hepatitis C virus-related knowledge and willingness to receive treatment among patients on methadone maintenanceBreaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV/HIV coinfection: action required at the system, provider, and patient levelsClinical Care Pathways for Patients With Hepatitis C: Reducing Critical Barriers to Effective Treatment.Evaluation of an integrated care service facility for people living with hepatitis C in New Zealand.Liver Disease Burden of Hepatitis C Virus Infection in Iran and the Potential Impact of Various Treatment Strategies on the Disease BurdenAccessing Hepatitis C patients who are difficult to reach: it is time to overcome barriers.Understanding barriers to hepatitis C virus care and stigmatization from a social perspective.Healthcare contact and treatment uptake following hepatitis C virus screening and counseling among rural Appalachian people who use drugs.HCV knowledge among a sample of HCV positive Aboriginal Australians residing in New South Wales.Evaluation of a hepatitis C education intervention with clients enrolled in methadone maintenance and needle/syringe programs in Malaysia.Treatment with direct-acting antiviral agents of hepatitis C virus infection in injecting drug users: A prospective study.Retention in buprenorphine treatment is associated with improved HCV care outcomes.Understanding decisions made about hepatitis C treatment by couples who inject drugs.No Differences in Achieving Hepatitis C Virus Care Milestones Between Patients Identified by Birth Cohort or Risk-Based Screening.Hepatitis C knowledge among gay and other homosexually active men in Australia.Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: the ETHOS study.Effectiveness of a decision aid for patients with depression: A randomized controlled trial.Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study.Hepatitis C point-of-care diagnostics: in search of a single visit diagnosis.Hepatitis C care continuum and associated barriers among people who inject drugs in Chennai, India.Experiences of liver health related uncertainty and self-reported stress among people who inject drugs living with hepatitis C virus: a qualitative study.A qualitative assessment of the acceptability of hepatitis C remote self-testing and self-sampling amongst people who use drugs in London, UK.
P2860
Q28550339-536D4933-96E5-4B66-94F1-96EBE278006DQ33884145-BDB9D979-4A8A-41CE-AFAB-D87F08DE4FB8Q34348710-31C59002-5A1E-4BC0-A2AA-7AA436614429Q35089934-BE0A9C9E-DC80-4A4D-87A4-4D68589C0C0AQ35839915-F52FDE71-095D-46F4-BC2A-5952BC5454BFQ35865346-71B400A2-C2B2-4AC9-858A-8FF71B381FE8Q36260469-CF9F7671-27BA-49FA-AC42-DAB019C63666Q36562909-7173BAB6-A847-4330-9BB7-5B33BF8C85AEQ36590782-294CE2D9-E7D0-4D23-9380-C6ED6A1C44DFQ36595579-31F1B70E-052E-4DDA-B0ED-C6A37DEB3D77Q36700770-E629F0EF-E693-4AFC-B0A3-4B09E13C6DADQ37246465-18B024EE-3044-455D-A47C-E9EF01392E3AQ38064495-7B0BB6A1-8B6A-441B-B618-69AB4526545BQ38123944-D8805DEB-32B6-4ADC-8D76-18630C9FE42BQ38710078-A61D1E6B-D829-4F82-B3FB-48CDF27D58ECQ38857464-D01B463E-19B6-4E19-A0C1-3944179A47FEQ40144817-134E5E1F-BD18-4D93-B98E-49F2181F70B1Q40272763-9450E96D-5979-4554-94A0-7498C71085C7Q40317993-7788FB4D-501F-4CA6-AFFD-1CEE217FA80EQ40608969-D69559E4-0413-4035-8E34-E9D7A1557734Q40701509-D2AB564D-7698-4CA5-BAC1-61FA6F016FFCQ41000731-1FB2CB13-2419-475E-A600-48F293DE6A18Q41210837-4F7AC227-F2FC-447B-BE8B-E5938E87F885Q41642775-FC7A8F96-9C5D-4DE0-8448-118D9EED31FAQ42280287-B685C648-D338-46DC-AB75-13F6AD00867AQ47594606-ED9F4053-23D1-4967-9195-9DF67547CA61Q54231086-0A6FEF91-E880-4830-956D-CD3D15B7B253Q55237856-3FF5D751-99A7-40F3-9912-C6888CD849D3Q55340444-EA805208-E0C2-4F90-8D57-58D510D48208
P2860
Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Knowledge and barriers associa ...... among people who inject drugs.
@en
Knowledge and barriers associa ...... among people who inject drugs.
@nl
type
label
Knowledge and barriers associa ...... among people who inject drugs.
@en
Knowledge and barriers associa ...... among people who inject drugs.
@nl
prefLabel
Knowledge and barriers associa ...... among people who inject drugs.
@en
Knowledge and barriers associa ...... among people who inject drugs.
@nl
P2093
P2860
P1476
Knowledge and barriers associa ...... among people who inject drugs.
@en
P2093
Carla Treloar
Gregory J Dore
Jason Grebely
Peter Hull
P2860
P304
P356
10.1111/J.1465-3362.2012.00468.X
P577
2012-05-21T00:00:00Z